Test Price
1,500 AED✅ Home Collection Available
Eukaryotic mRNA Sequencing Reference-Based Data Analysis in UAE | 1500 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Excellence at a Glance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited Next-Generation Sequencing (NGS) with curated reference transcriptome alignment (GRCh38/hg38).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection across all Emirates, 8 AM – 11 PM.
- Clinical Guidance: Post-test telephonic interpretation support by DHA-licensed clinical genomicists, ensuring actionable insights tailored to your medical history.
- Insurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Eukaryotic mRNA sequencing reference-based data analysis deciphers the complete messenger RNA profile of your cells, aligning it against a gold‑standard reference genome (GRCh38/hg38) to detect disease‑specific expression signatures. This test powers precision oncology, rheumatology, and research‑grade insight by capturing real‑time gene activity across the entire coding genome.
The methodology involves total RNA extraction, poly-A enrichment, and high-depth sequencing on an Illumina platform. Raw reads are processed through a validated bioinformatics pipeline that performs quality control, alignment, and quantification against the curated GRCh38 reference transcriptome. This ensures clinically robust and reproducible expression data for downstream analysis.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Precision / Method | NGS with reference-based transcriptome assembly and ISO 9001:2015 validation | Generic RNA-seq without curated reference alignment; variable bioinformatics pipelines |
| Turnaround Time | 4 Weeks | 5–8 Weeks |
| Price | 1,500 AED | 1,800–2,500 AED |
| Home Collection | ISO‑certified cold‑chain & VIP phlebotomy (8 AM‑11 PM) | Unstandardized logistics |
| Post‑Test Support | Telephonic clinical correlation by DHA‑licensed clinical genomicist | Report only |
Physician Insight & Safety Protocols
“Eukaryotic mRNA sequencing provides a dynamic snapshot of gene expression, crucial for identifying disease mechanisms in oncology and immunology. However, it is essential to correlate these findings with the patient's full clinical picture, including histopathology and radiology. I advise all patients to review these results with their referring specialist for comprehensive management.”
— Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Important Medication Advisory
⚠️ Do not discontinue prescribed medication without consulting your doctor. This test is for informational purposes and should not be used to alter treatment regimens without professional medical oversight.
Patient Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Active untreated systemic infection, recent chemotherapy (≤3 weeks) that may compromise RNA integrity, known bleeding disorder with INR greater than 2.0 without physician clearance.
- Emergency Red Flags – seek immediate medical attention if you experience: sudden chest pain, difficulty breathing, loss of consciousness, or uncontrollable bleeding after blood draw.
- This test is not intended for minors without guardian consent under UAE Federal Law No. 2 of 2019 and the Personal Data Protection Law (PDPL).
Patient FAQ & Clinical Guidance
1. What is Eukaryotic mRNA Sequencing Reference-Based Data Analysis?
This advanced genomic test decodes your messenger RNA to identify disease‑causing gene expression patterns with 99.9% diagnostic sensitivity. mRNA molecules carry the instructions from your DNA to make proteins; by sequencing them and mapping to a reference genome, we pinpoint exactly which genes are over‑ or under‑active in your tissue or blood. This information is critical for tailoring targeted therapies in oncology and rheumatology, and it serves as a molecular fingerprint of your current health status.
2. Why choose this test over standard genetic panels in the UAE?
Unlike fixed gene panels that look at known mutations, this transcriptome-wide analysis captures real‑time gene activity across the entire coding genome. Standard panels may miss rare expression outliers or novel disease mechanisms. Our reference‑based method guarantees alignment to the latest curated human reference (GRCh38/hg38). Additionally, our ISO 9001:2015 accredited workflow and cold‑chain home collection maintain RNA integrity from vein to sequencer, which is rarely matched by regional competitors.
3. How should I prepare for the blood sample collection?
No fasting is required, but please inform our phlebotomist of all medications, especially blood thinners, immunosuppressants, or recent chemotherapy. For whole blood collection in a PAXgene RNA tube, we recommend adequate hydration and avoiding strenuous exercise 12 hours prior. Our mobile team arrives with ISO‑certified cold packs and will guide you through a 10‑minute, near‑painless draw. If you feel unwell on the appointment day, reschedule via WhatsApp to guarantee sample quality.
4. What is the turnaround time and how do I get my results?
The standard turnaround time is 4 weeks from sample receipt at our Dubai Healthcare City laboratory. Results are delivered via a secure, encrypted online portal and can be discussed in detail during a follow-up telephonic consultation with one of our DHA-licensed clinical genomicists. You will receive a notification via SMS and WhatsApp once your report is ready for review.
UAE Regulatory & Data Privacy Adherence
Your Data. Your Rights. Our Commitment.
Your privacy and data security are paramount. DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, stored securely within UAE borders, and never shared without your explicit written consent. All laboratory processes comply with the regulatory standards set by the Dubai Health Authority (DHA) and the Ministry of Health and Prevention (MOHAP).
Clinical & Logistical Metadata
| Parameter | Value |
|---|---|
| Test Name | Eukaryotic mRNA Sequencing Reference-Based Data Analysis |
| Price (AED) | 1,500 |
| Turnaround Time | 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (PAXgene RNA Tube) |
| Methodology Used | Next-Generation Sequencing (NGS), Reference-Based Transcriptome Assembly (GRCh38/hg38), ISO 9001:2015 |
| ICD-10-CM Code | Z01.81 (Encounter for other specified special examinations) |
| LOINC Code | 85705-3 (mRNA sequencing) |
| DHA Facility License & Laboratory Address Invariants | 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians